BW-19
UNII Y7Y41ZW429
Substance Identification & Data
This profile provides standardized clinical and technical data for Bw-19, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Y7Y41ZW429.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 221651-26-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Y7Y41ZW429
221651-26-9
N/A
Detailed Substance Profile
Preferred Name
BW-19
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C16H18N2O International Chemical Identifier digital signature for unique molecular identification.
SMILES String
GEXYIIUWEYUZRJ-UHFFFAOYSA-N Line notation for describing the chemical structure and connectivity of atoms.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c1ncc([nH]1)CC2=C(c3ccc(cc3CC2)OC)C
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Bw-19. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
Common Names & Synonyms
BW-19
Systematic Nomenclature
1H-IMIDAZOLE, 4-((3,4-DIHYDRO-6-METHOXY-1-METHYL-2-NAPHTHALENYL)METHYL)-
1H-IMIDAZOLE, 5-((3,4-DIHYDRO-6-METHOXY-1-METHYL-2-NAPHTHALENYL)METHYL)-